Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Vivos (RDGL) Cash from Financing Activities (2016 - 2025)

Vivos' Cash from Financing Activities history spans 15 years, with the latest figure at -$845.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 100.06% to -$845.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 34.6% decrease, with the full-year FY2025 number at $1.5 million, down 34.6% from a year prior.
  • Cash from Financing Activities hit -$845.0 in Q4 2025 for Vivos, down from $1.5 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for RDGL hit a ceiling of $1.8 million in Q1 2021 and a floor of -$145000.0 in Q4 2021.
  • Historically, Cash from Financing Activities has averaged $667335.9 across 4 years, with a median of $518580.0 in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 2420.16% in 2021, down 111.56% in 2021.
  • Tracing RDGL's Cash from Financing Activities over 4 years: stood at -$145000.0 in 2021, then soared by 457.64% to $518580.0 in 2023, then surged by 182.56% to $1.5 million in 2024, then plummeted by 100.06% to -$845.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for RDGL at -$845.0 in Q4 2025, $1.5 million in Q1 2025, and $1.5 million in Q4 2024.